Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000778217 | SCV000914383 | pathogenic | Autosomal recessive early-onset Parkinson disease 6 | 2018-10-11 | criteria provided, single submitter | clinical testing | The PINK1 c.774C>A (p.Tyr258Ter) variant is a stop-gained variant predicted to result in premature termination of the protein. The p.Tyr258Ter variant has been reported in four studies in which it is found in a homozygous state in a total of six individuals (including three siblings) with autosomal recessive Parkinson disease (Tan et al. 2006; Keyser et al. 2010; Haylett et al. 2012; Al-Rumayyan et al. 2017). One individual first presented with symptoms at aged five years (Al-Rumayyan et al. 2017). The p.Tyr258Ter variant has been reported to segregate with Parkinson in one family and found in a heterozygous state in the unaffected parents of one proband and unaffected family members in a second (Keyser et al. 2010; Al-Rumayyan et al. 2017). The variant was absent from 530 control chromosomes and is reported at a frequency of 0.00009 in the South Asian population of the Exome Aggregation Consortium, but this is based on one allele in a region of good sequence coverage, so the variant is presumed to be rare. Based on the evidence and the potential impact of stop-gained variants, the p.Tyr258Ter variant is classified as pathogenic for autosomal recessive Parkinson disease. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Biochemical Molecular Genetic Laboratory, |
RCV000778217 | SCV001133094 | likely pathogenic | Autosomal recessive early-onset Parkinson disease 6 | 2019-09-26 | no assertion criteria provided | clinical testing |